GENETIC CHEMISTRY
DEAD

Serial Number

98327493

Owner

Empress Therapeutics, Inc.

Attorney

Christina M. Licursi

Filing Date

Dec 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GENETIC CHEMISTRY Trademark

Serial Number: 98327493

GENETIC CHEMISTRY is a trademark filed by Empress Therapeutics, Inc. on December 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Empress Therapeutics, Inc. (19 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

December 22, 2023

Registration Date

Not Registered

Goods & Services

Pharmaceutical research and development; scientific and medical research and development; technical scientific research consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and microbial products; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, pharmaceuticals, and microbial products; drug discovery platform

Pharmaceuticals, namely, pharmaceutical preparations for treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders; therapeutics in the nature of oral products, injectables, topical products, inhalation products, ophthalmic products, otic products, nasal products, rectal products, vaginal products, implants, infusions, transdermal systems, and oral thin films; therapeutic pharmaceuticals for the treatment of cancer, inflammatory diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, and neurodegenerative diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 15, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 15, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 30, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 30, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 30, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 28, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2024 NWOS
NEW APPLICATION ENTERED
Dec 22, 2023 NWAP